IBD Archive — Page 1 of 1

Medical professional in gloves holds an ultrasound probe against a patient’s abdomen beside an ultrasound machine.
January 9, 2024

Innovations improve the lives of patients with IBD

Two recent innovations — point-of-care intestinal ultrasound and functional medicine — are improving the lives of patients at the Vanderbilt Inflammatory Bowel Disease Clinic at Vanderbilt Health One Hundred Oaks.

Research by Christopher Peek, PhD, left, Jim Cassat, MD, PhD, and their colleagues reveals how gut inflammation leads to bone loss.
August 25, 2022

Vanderbilt researchers discover how gut inflammation leads to bone loss

Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of “bone-eating” cells, leading to bone loss.

Illustration of a magnifying glass enlarging green, curved microbe-like shapes over a stylized red intestinal tract.
March 4, 2021

Probiotic protection

A probiotic factor given early in life to mice prevented intestinal inflammation in adulthood, providing a rationale for probiotic intervention in individuals at high risk of developing inflammatory bowel disease.

Jennifer Pilat, left, Sarah Short, PhD, Christopher Williams, MD, PhD, and colleagues are studying a biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.
February 4, 2021

Potential biomarker for IBD severity, cancer risk identified

A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.

Stylized medical illustration of intertwined intestinal loops glowing orange and red against a dark blue abdominal silhouette, with scattered dark circular markings on the intestines.
July 19, 2018

Novel insights on “leaky” gut

A protein involved in binding cells together helps maintain the integrity of the intestinal mucosa and plays a protective role in ulcerative colitis.